Bank of New York Mellon Corp
BankPosition in JANX — Janux Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in JANX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,665,579
-$18,930 QoQ
Shares Held
119,826
-1.8% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. JANX ranks #143 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in JANX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,665,579 | 119,826 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,684,509 | 122,066 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,944,333 | 120,472 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,649,543 | 114,699 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $2,412,990 | 89,370 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $4,222,109 | 78,859 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $3,944,912 | 86,835 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,818,478 | 115,027 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,833,064 | 48,687 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $565,964 | 52,746 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $534,733 | 53,049 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $629,691 | 53,049 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $642,400 | 53,091 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $704,659 | 53,505 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $678,258 | 50,093 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $517,532 | 42,386 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $659,653 | 46,001 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $720,874 | 36,537 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $680,760 | 31,473 | Shares | Defined | 2021-11-18 | |
| No filing history on record for this holder in this stock. | ||||||